Trial Information
Understanding Patient Perspectives on the Risks of Ionizing Radiation Used for Medical Imaging
Inclusion Criteria:
- English-language fluent
- 18 years of age, or older
- Provide informed consent
- Group 1: Patients undergoing chemotherapy for Stage IV colorectal carcinoma.
- Group 2: Parents of pediatric patients who have undergone treatment for stage 1-3
neuroblastoma.
- Group 3: Women who have undergone treatment for early stage breast cancer within the
preceding 6 months.
- Group 4: Men undergoing surveillance imaging after treatment for testicular cancer.
- Group 5: Patients currently or previously enrolled in the MSKCC lung cancer screening
program.
- Group 6: Patients enrolled in or eligible for the thoracic survivorship program.
Exclusion Criteria:
- Participants who don't speak English
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
characterize participant knowledge, attitudes
Outcome Description:
about imaging radiation, information sources, and satisfaction with risk-benefit communication.
Outcome Time Frame:
2 years
Safety Issue:
No
Principal Investigator
Raymond Thornton, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Memorial Sloan-Kettering Cancer Center
Authority:
United States: Institutional Review Board
Study ID:
11-185
NCT ID:
NCT01482741
Start Date:
November 2011
Completion Date:
November 2013
Related Keywords:
- Breast Cancer
- Colon Cancer
- Lung Cancer
- Neuroblastoma
- Testicular Cancer
- Quality of Life
- Focus groups
- Risks of Ionizing Radiation
- Risk of medical imaging
- 11-185
- Breast Neoplasms
- Colonic Neoplasms
- Lung Neoplasms
- Neuroblastoma
- Testicular Neoplasms
Name | Location |
Memorial Sloan-Kettering Cancer Center |
New York, New York 10021 |